These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7889813)

  • 1. Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients.
    Kidorf M; Stitzer ML; Brooner RK; Goldberg J
    Drug Alcohol Depend; 1994 Dec; 36(3):221-6. PubMed ID: 7889813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment program.
    Peles E; Schreiber S; Sason A; Adelson M
    J Addict Med; 2011 Jun; 5(2):92-8. PubMed ID: 21769054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingent take-home incentive: effects on drug use of methadone maintenance patients.
    Stitzer ML; Iguchi MY; Felch LJ
    J Consult Clin Psychol; 1992 Dec; 60(6):927-34. PubMed ID: 1460154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of methadone take-home contingencies with persistent opiate and cocaine abusers.
    Chutuape MA; Silverman K; Stitzer ML
    J Subst Abuse Treat; 1999 Jan; 16(1):23-30. PubMed ID: 9888118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey assessment of methadone treatment services as reinforcers.
    Chutuape MA; Silverman K; Stitzer ML
    Am J Drug Alcohol Abuse; 1998 Feb; 24(1):1-16. PubMed ID: 9513626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing opiate abstinence through voucher-based reinforcement therapy.
    Silverman K; Wong CJ; Higgins ST; Brooner RK; Montoya ID; Contoreggi C; Umbricht-Schneiter A; Schuster CR; Preston KL
    Drug Alcohol Depend; 1996 Jun; 41(2):157-65. PubMed ID: 8809505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.
    Preston KL; Umbricht A; Epstein DH
    Arch Gen Psychiatry; 2000 Apr; 57(4):395-404. PubMed ID: 10768702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers.
    Rogers RE; Higgins ST; Silverman K; Thomas CS; Badger GJ; Bigelow G; Stitzer M
    Psychol Addict Behav; 2008 Dec; 22(4):544-50. PubMed ID: 19071979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone dosages and therapeutic compliance during a methadone maintenance program.
    Maremmani I; Nardini R; Zolesi O; Castrogiovanni P
    Drug Alcohol Depend; 1994 Jan; 34(2):163-6. PubMed ID: 8026304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled use of heroin in patients on methadone maintenance treatment.
    Bianchi E; Maremmani I; Meloni D; Tagliamonte A
    J Subst Abuse Treat; 1992; 9(4):383-7. PubMed ID: 1479633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What happens when contingency management treatment ends? A tale of two clients.
    Petry NM; Kelley L; Brennan M; Sierra S
    Am J Addict; 2008; 17(3):241-4. PubMed ID: 18464002
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patients.
    Sigmon SC; Stitzer ML
    J Subst Abuse Treat; 2005 Dec; 29(4):253-8. PubMed ID: 16311177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple reinforcement system for methadone clients in a community-based treatment program.
    Rowan-Szal G; Joe GW; Chatham LR; Simpson DD
    J Subst Abuse Treat; 1994; 11(3):217-23. PubMed ID: 8072049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attendance rates in a workplace predict subsequent outcome of employment-based reinforcement of cocaine abstinence in methadone patients.
    Donlin WD; Knealing TW; Needham M; Wong CJ; Silverman K
    J Appl Behav Anal; 2008; 41(4):499-516. PubMed ID: 19192855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women.
    Jones HE; Haug N; Silverman K; Stitzer M; Svikis D
    Drug Alcohol Depend; 2001 Feb; 61(3):297-306. PubMed ID: 11164694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients.
    Schmitz JM; Rhoades H; Grabowski J
    Addict Behav; 1995; 20(2):171-9. PubMed ID: 7484311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined behavioral and pharmacological treatment of alcoholic methadone patients.
    Bickel WK; Rizzuto P; Zielony RD; Klobas J; Pangiosonlis P; Mernit R; Knight WF
    J Subst Abuse; 1988-1989; 1(2):161-71. PubMed ID: 2980867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interdependent group contingency management for cocaine-dependent methadone maintenance patients.
    Kirby KC; Kerwin ME; Carpenedo CM; Rosenwasser BJ; Gardner RS
    J Appl Behav Anal; 2008; 41(4):579-95. PubMed ID: 19192861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving treatment engagement and outcomes for cocaine-using methadone patients.
    Villano CL; Rosenblum A; Magura S; Fong C
    Am J Drug Alcohol Abuse; 2002; 28(2):213-30. PubMed ID: 12014813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.